In vitro assessment of synergistic effects in combinations of a temoporfin-based photodynamic therapy with glutathione peroxidase 1 inhibitors

Background - Due to an increased elimination of reactive oxygen species (ROS), in particular hydrogen peroxide (H2O2), overexpression of glutathione peroxidase 1 (GPX1) can lead to an attenuation of apoptosis and development of resistance in cancer cells, thereby promoting tumor cell survival. Conse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lange, Carsten (VerfasserIn) , Bednarski, Patrick J. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 August 2021
In: Photodiagnosis and photodynamic therapy
Year: 2021, Jahrgang: 36, Pages: 1-11
ISSN:1873-1597
DOI:10.1016/j.pdpdt.2021.102478
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.pdpdt.2021.102478
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1572100021003021
Volltext
Verfasserangaben:Carsten Lange, Patrick J. Bednarski

MARC

LEADER 00000caa a2200000 c 4500
001 1777154456
003 DE-627
005 20230426232551.0
007 cr uuu---uuuuu
008 211110s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.pdpdt.2021.102478  |2 doi 
035 |a (DE-627)1777154456 
035 |a (DE-599)KXP1777154456 
035 |a (OCoLC)1341423466 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lange, Carsten  |d 1985-  |e VerfasserIn  |0 (DE-588)1201606802  |0 (DE-627)168567223X  |4 aut 
245 1 0 |a In vitro assessment of synergistic effects in combinations of a temoporfin-based photodynamic therapy with glutathione peroxidase 1 inhibitors  |c Carsten Lange, Patrick J. Bednarski 
264 1 |c 8 August 2021 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.11.2021 
520 |a Background - Due to an increased elimination of reactive oxygen species (ROS), in particular hydrogen peroxide (H2O2), overexpression of glutathione peroxidase 1 (GPX1) can lead to an attenuation of apoptosis and development of resistance in cancer cells, thereby promoting tumor cell survival. Consequently, GPX1 inhibitors have the potential to be used in cancer therapy as they support oxidative stress in cancer cells. Similarly, photodynamic therapy (PDT) induces oxidative stress in cancer cells by the formation of ROS upon illumination. Thus, both methods of treatment might act in synergy when used in combination. - Methods - To investigate this hypothesis, combinations of the known GPX1 inhibitors 9-chloro-6-ethyl-6H-[1,2,3,4,5]pentathiepino[6,7-b]indole (CEPI) or mercaptosuccinic acid (MSA) with PDT induced by the photosensitizer (PS) temoporfin (5,10,15,20-tetra(m-hydroxyphenyl)chlorin, mTHPC) were studied in vitro. This new combinatory approach was intended to accumulate ROS formed during PDT via blockage of GPX1-catalyzed H2O2 degradation, and thus to enhance PDT-induced phototoxicity. Five human cancer cell lines from tumor origins treatable with PDT were utilized to investigate ROS generation, apoptosis induction, and cell cycle distribution. - Results - Synergy was identified with both GPX1 inhibitors, but not in all cell lines. ROS levels were increased after combined treatment with mTHPC and CEPI, but not MSA, in some cell lines, indicating that oxidative stress and ROS accumulation were enhanced by CEPI. Surprisingly, enhanced apoptosis induction was also observed with MSA afterwards, suggesting that other pathways contributed to the initiation of apoptosis. Cell cycle analysis confirmed apoptosis induction via the detection of DNA fragmentation. - Conclusion - A combination of GPX1 inhibitors with mTHPC-PDT has the potential to generate synergistic effects and to increase overall phototoxicity, but the success of this combination approach was dependent on cancer type, and even antagonistic effects can occur. 
650 4 |a Cancer therapy 
650 4 |a Combination assay 
650 4 |a Glutathione peroxidase inhibitor 
650 4 |a mTHPC 
650 4 |a Photodynamic therapy 
650 4 |a Reactive Oxygen Species 
650 4 |a Synergism 
700 1 |a Bednarski, Patrick J.  |e VerfasserIn  |0 (DE-588)1245485237  |0 (DE-627)1777151619  |4 aut 
773 0 8 |i Enthalten in  |t Photodiagnosis and photodynamic therapy  |d Amsterdam [u.a.] : Elsevier Science, 2004  |g 36(2021) vom: Dez., Artikel-ID 102478, Seite 1-11  |h Online-Ressource  |w (DE-627)389871893  |w (DE-600)2149918-4  |w (DE-576)259486337  |x 1873-1597  |7 nnas  |a In vitro assessment of synergistic effects in combinations of a temoporfin-based photodynamic therapy with glutathione peroxidase 1 inhibitors 
773 1 8 |g volume:36  |g year:2021  |g month:12  |g elocationid:102478  |g pages:1-11  |g extent:11  |a In vitro assessment of synergistic effects in combinations of a temoporfin-based photodynamic therapy with glutathione peroxidase 1 inhibitors 
856 4 0 |u https://doi.org/10.1016/j.pdpdt.2021.102478  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1572100021003021  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211110 
993 |a Article 
994 |a 2021 
998 |g 1201606802  |a Lange, Carsten  |m 1201606802:Lange, Carsten  |d 910000  |d 910400  |e 910000PL1201606802  |e 910400PL1201606802  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1777154456  |e 4001306506 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Carsten Lange, Patrick J. Bednarski"]},"origin":[{"dateIssuedDisp":"8 August 2021","dateIssuedKey":"2021"}],"id":{"doi":["10.1016/j.pdpdt.2021.102478"],"eki":["1777154456"]},"physDesc":[{"extent":"11 S."}],"relHost":[{"id":{"zdb":["2149918-4"],"eki":["389871893"],"issn":["1873-1597"]},"origin":[{"publisher":"Elsevier Science","dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisherPlace":"Amsterdam [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Photodiagnosis and photodynamic therapy","title":"Photodiagnosis and photodynamic therapy"}],"part":{"text":"36(2021) vom: Dez., Artikel-ID 102478, Seite 1-11","volume":"36","extent":"11","year":"2021","pages":"1-11"},"pubHistory":["1.2004 -"],"language":["eng"],"recId":"389871893","note":["Gesehen am 01.06.23"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"In vitro assessment of synergistic effects in combinations of a temoporfin-based photodynamic therapy with glutathione peroxidase 1 inhibitorsPhotodiagnosis and photodynamic therapy"}],"person":[{"display":"Lange, Carsten","roleDisplay":"VerfasserIn","role":"aut","family":"Lange","given":"Carsten"},{"display":"Bednarski, Patrick J.","roleDisplay":"VerfasserIn","role":"aut","family":"Bednarski","given":"Patrick J."}],"title":[{"title":"In vitro assessment of synergistic effects in combinations of a temoporfin-based photodynamic therapy with glutathione peroxidase 1 inhibitors","title_sort":"In vitro assessment of synergistic effects in combinations of a temoporfin-based photodynamic therapy with glutathione peroxidase 1 inhibitors"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 10.11.2021"],"recId":"1777154456","language":["eng"]} 
SRT |a LANGECARSTINVITROASS8202